4D Molecular Therapeutics
Price & Volume
Stats
See more52W Range | $3.55-$12.34 |
Market Cap | $468.9M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $88.2M |
Revenue Growth (YoY) | 21,664.3% |
Gross Profit (12 Mos) | -$128.5M |
Diluted EPS | -$2.57 |
News
See moreYahoo Finance • 10 days ago
4D Molecular Therapeutics Inc (FDMT): Gene Therapy Stock Made for You?
Yahoo Finance • 15 days ago
4DMT Announces New Employment Inducement Grants
Yahoo Finance • 2 months ago
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Yahoo Finance • 3 months ago
4DMT to Participate in Upcoming Investor Conferences
About
CEO | Dr. David H. Kirn M.D. |
CFO | Mr. Kristian Humer M.B.A. |
Address | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 196 |